NumFin

Gland Pharma Limited

符号: GLAND.NS

NSE

1708.85

INR

今天的市场价格

  • 42.9265

    市盈率

  • 1.6233

    PEG比率

  • 281.47B

    MRK市值

  • 0.00%

    DIV收益率

Gland Pharma Limited (GLAND-NS) 财务报表

Download
年度季度
线性对数
在图表中，您可以看到 的动态默认数字 Gland Pharma Limited (GLAND.NS). 的默认数据。公司收入显示 27223.644 M 的平均值，即 0.163 % 增长率。整个期间的平均毛利润为 15096.8 M，即 0.140 %. 平均毛利率为 0.564 %. 公司去年的净收入增长率为 -0.355 %，等于 0.193 % % 整个公司历史的平均增长率.,

年度季度
10Y20Y30Y40Y

资产负债表

深入分析 Gland Pharma Limited 的财务轨迹，我们可以看到其平均资产增长率。有趣的是，这一增长率为 ，反映了公司的高点和低点。与季度相比，这一数字调整为0. 回顾过去一年，总资产变化为 0.206. 在流动资产领域，GLAND.NS 的报告货币为69008.08. 这些资产中的很大一部分，即 38361.96 是现金和短期投资。与去年的数据相比，该部分的变化率为0.183%. 公司的债务概况显示，以报告货币计算的长期债务总额为 37.44. 这一数字表明，-0.050% 的年同比变化. 股东权益总额所体现的股东价值是以报告货币计算的 79587.22. 这方面的年同比变化率为 0.112%. 深入了解公司财务信息后，会发现更多细节。应收账款净额的估值为8715.33，存货估值为 19453，商誉估值为 0（如有. 无形资产总额（如果有）按 116.61 估值.

common:word.in-mln

USD
Growth
TTM2022202120202019201820172016

balance-sheet.row.cash-and-short-term-investments

119605.73836232427.224465
13122.3
7207.5
6511.4
5330.8

balance-sheet.row.short-term-investments

154862.641927329268.919546.8
11427.3
4843.4
2783
0

balance-sheet.row.net-receivables

22690.468715.312514.712726.8
7767.3
5520.5
0
0

balance-sheet.row.inventory

40296.481945311856.712751.7
7562.8
9118.8
5128.3
3787.2

balance-sheet.row.other-current-assets

5282.692477.81722.31292.9
10.5
7248.3
5681.9
0

balance-sheet.row.total-current-assets

187875.3369008.158520.851236.4
28462.9
23574.6
17321.6
14081.5

balance-sheet.row.property-plant-equipment-net

51493.3173611726913244.4
11969
10950.3
10464.7
10327.3

balance-sheet.row.goodwill

4555.95000
0
0
0
0

balance-sheet.row.intangible-assets

1656.81116.6125.30
0
0
0
0

balance-sheet.row.goodwill-and-intangible-assets

6212.76116.6125.30
0
0
0
0

balance-sheet.row.long-term-investments

-16835.11-733.72000-19477.3
16.6
13.3
0
0

balance-sheet.row.tax-assets

1402.64958.9-415.10
0
0
0
0

balance-sheet.row.other-non-current-assets

-39445.191064.4836.119957.3
411.9
697.4
1508.4
-10327.3

balance-sheet.row.total-non-current-assets

2828.418767.319815.413724.4
12397.5
11660.9
11973
10327.3

balance-sheet.row.other-assets

0000
0
0
0
328.6

balance-sheet.row.total-assets

190703.7387775.478336.264960.8
40860.4
35235.5
29294.7
24737.5

balance-sheet.row.account-payables

15655.985873.54628.54007.3
2490.9
4462
2918.1
1892.9

balance-sheet.row.short-term-debt

2102.997.12.63
10.2
6.2
5.1
0

balance-sheet.row.tax-payables

624.799.8179.8286.9
107.2
110
129
0

balance-sheet.row.long-term-debt-total

1511.8437.444.847
49.9
60.1
66.3
59.2

Deferred Revenue Non Current

1298.8949.955.556.7
58
201.6
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

2180.49---
-
-
-
-

balance-sheet.row.other-current-liab

3290.63924.7552.663.3
171.2
117.9
38.7
641

balance-sheet.row.total-non-current-liabilities

5396.07896.8939.8803.1
807.8
1287.8
1399.2
59.2

balance-sheet.row.other-liabilities

0000
0
0
0
1246.3

balance-sheet.row.capital-lease-obligations

449.536.38.19.3
10.5
11.4
12.2
0

balance-sheet.row.total-liab

28049.428188.167605928.4
4398
6615.5
5191.1
3839.3

balance-sheet.row.preferred-stock

15.5915.600
0
0
0
0

balance-sheet.row.common-stock

329.4164.7164.3163.6
154.9
154.9
154.9
154.9

balance-sheet.row.retained-earnings

60153.8860153.952343.440226.8
30257.2
22527.5
18008.9
15579.3

balance-sheet.row.accumulated-other-comprehensive-income-loss

245541.11-15.6114.5240.9
160.3
47.6
0
0

balance-sheet.row.other-total-stockholders-equity

19268.6419268.618953.918401.1
5889.9
5889.9
5939.7
-15734.2

balance-sheet.row.total-stockholders-equity

325308.6279587.271576.259032.4
36462.3
28620
24103.6
15734.2

balance-sheet.row.total-liabilities-and-stockholders-equity

353358.0487775.478336.264960.8
40860.4
35235.5
29294.7
0

balance-sheet.row.minority-interest

0000
0
0
0
0

balance-sheet.row.total-equity

325308.6279587.271576.259032.4
36462.3
28620
24103.6
-

balance-sheet.row.total-liabilities-and-total-equity

353358.04---
-
-
-
-

Total Investments

138027.5318539.3200069.5
11427.3
4843.4
2783
0

balance-sheet.row.total-debt

3614.8344.547.450
60.1
66.3
71.4
0

balance-sheet.row.net-debt

38871.77-19044.4-3110.8-4868.3
-1634.9
-2297.7
-3657
-5330.8

现金流量表

在 Gland Pharma Limited 的财务状况中，自由现金流在过去一段时间内发生了显著变化，呈现出 -0.286 的转变。该公司最近通过发行 214.96 扩大了股本，与上一年相比出现了0.243 的差异. 有趣的是，公司的部分股票，特别是 0，是由公司自己回购的。这一举动导致0.000 比上一年有所变化。同时，以报告货币计算，公司的应付账款目前为 1209.76. 公司的投资活动产生了现金使用净额，按报告货币计算达到12081880000.000. 与上一年相比， -2.205 发生了变化. 在同一时期，公司记录了 1467.36, 14313.07 和 -1.12，这对于了解公司的投资和还款策略具有重要意义. 公司的融资活动导致使用的现金净额为0.000，同比差异为0.000. 此外，公司还将0 用于向股东分红。与此同时，该公司还采取了其他财务措施，即 -64.65，这也对其在此期间的现金流产生了重大影响. 这些组成部分合在一起，全面反映了公司的财务状况和现金流管理的战略方针。

common:word.in-mln

USD
Growth
TTM2022202120202019201820172016

cash-flows.row.net-income

6587.2310545.816185.513348.1
9928.7
6862.8
5014.6
4137.3

cash-flows.row.depreciation-and-amortization

2894.991467.41103987.8
945.9
821.2
783.7
741.5

cash-flows.row.deferred-income-tax

00-4143.8-3254
-2778.3
0
0
0

cash-flows.row.stock-based-compensation

0046.2155.3
164.8
0
0
0

cash-flows.row.change-in-working-capital

0-4179.4-3930.8-4357.6
-799.4
-3539.4
-1934.3
-867.3

cash-flows.row.account-receivables

01440-4195.7-602
-805.2
-459
0
-750.9

cash-flows.row.inventory

0-7596.3895-5188.9
1556
-3990.5
-1341.1
-116.4

cash-flows.row.account-payables

01209.8658.51428.2
-2146.7
1130.1
0
0

cash-flows.row.other-working-capital

0767.2-1288.65.1
596.5
-220.2
-593.2
0

cash-flows.row.other-non-cash-items

-6587.23-4194.1-1352.4-830.4
-452.4
-2292
-1842.9
753.2

cash-flows.row.net-cash-provided-by-operating-activities

5789.98000
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-2231.2-5221.2-2287.8
-1946.6
-1357.4
-851.8
-1161.9

cash-flows.row.acquisitions-net

0-12705.66117.24.3
238.9
5.5
0
0

cash-flows.row.purchases-of-investments

0-4699.8-16818.1-13575.9
-6387.5
-2187.4
-2982
0

cash-flows.row.sales-maturities-of-investments

017405.410700.9-4.3
-238.9
-5.5
0
0

cash-flows.row.other-investing-activites

014313.1-4805623.7
673.3
403.5
245.4
195.3

cash-flows.row.net-cash-used-for-investing-activites

012081.9-10026.2-15240
-7660.8
-3141.4
-3588.4
-966.5

cash-flows.row.debt-repayment

0-1.1-1.4-8.9
-5.3
-4.3
-4.6
0

cash-flows.row.common-stock-issued

0215385.512418.1
0
0
3976.8
0

cash-flows.row.common-stock-repurchased

0000
0
0
-3976.8
0

cash-flows.row.dividends-paid

0000
0
0
0
0

cash-flows.row.other-financing-activites

0-64.7-35.2-24.6
-63.4
-27
-33.1
-1164.2

cash-flows.row.net-cash-used-provided-by-financing-activities

0149.234912384.6
-68.7
-31.2
-37.7
-1164.2

cash-flows.row.effect-of-forex-changes-on-cash

03033.135.8
51.1
-44.3
2.6
-35.4

cash-flows.row.net-change-in-cash

5789.9815900.8-1736.43229.7
-669
-1364.4
-1602.4
2598.5

cash-flows.row.cash-at-end-of-period

51207.44190893188.24924.6
1695
2364
3728.4
5330.8

cash-flows.row.cash-at-beginning-of-period

45417.463188.24924.61695
2364
3728.4
5330.8
2732.3

cash-flows.row.operating-cash-flow

5789.983639.77907.76049.3
7009.4
1852.5
2021.1
4764.6

cash-flows.row.capital-expenditure

0-2231.2-5221.2-2287.8
-1946.6
-1357.4
-851.8
-1161.9

cash-flows.row.free-cash-flow

5789.981408.52686.53761.5
5062.7
495.1
1169.4
3602.7

利润表行

Gland Pharma Limited 的收入与上期相比变化了 0.281%。据报告, GLAND.NS 的毛利润为 19391.74。该公司的营业费用为 10611.47，与上年相比变化了 21.336%. 折旧和摊销费用为 1467.36，与上一会计期间相比变化了 0.330%. 营业费用报告为 10611.47，显示21.336% 的同比变化。 销售和营销费用为 0, 其中 0.000% 与上年相比发生了变化。 基于近期数据的EBITDA为 0，同比增长0.209%. 营业收入为 8844.4，与上年相比变化了-0.368%. 净利润的变化率为 -0.355%。去年的净收入为7810.43.

common:word.in-mln

USD
Growth
TTM2022202120202019201820172016

income-statement-row.row.total-revenue

49122.833624643841.434236.4
25717.8
19931.5
15800.6
14791.8

income-statement-row.row.cost-of-revenue

19385.4716854.321092.214918.7
11020.2
8570.2
6607.5
5824.8

income-statement-row.row.gross-profit

29737.3619391.722749.319317.6
14697.6
11361.3
9193.1
8967

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0

income-statement-row.row.research-development

2016---
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-

income-statement-row.row.other-expenses

1670.272404.61682.8
9.8
5.8
2.8
0

income-statement-row.row.operating-expenses

21203.9410611.58745.57280.4
6072.6
5222.7
4611.1
-3315.1

income-statement-row.row.cost-and-expenses

40589.4127465.729837.722199.2
17092.8
13792.9
11218.6
2509.6

income-statement-row.row.interest-income

1783.741794.21386.5859.5
514.9
433.1
271.7
128.2

income-statement-row.row.interest-expense

184.4574.53429.1
62.5
26.2
32.5
0

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-

income-statement-row.row.total-other-income-expensenet

190.971701.42185.21313.7
1319.9
619
432.6
201.4

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-

income-statement-row.row.other-operating-expenses

1670.272404.61682.8
9.8
5.8
2.8
0

income-statement-row.row.total-operating-expenses

190.971701.42185.21313.7
1319.9
619
432.6
201.4

income-statement-row.row.interest-expense

184.4574.53429.1
62.5
26.2
32.5
0

income-statement-row.row.depreciation-and-amortization

2894.991467.41103987.8
945.9
821.2
783.7
741.5

income-statement-row.row.ebitda-caps

12534.07---
-
-
-
-

income-statement-row.row.operating-income

9263.668844.414000.312034.5
8608.8
6243.8
4582
5578.7

income-statement-row.row.income-before-tax

9454.6310545.816185.513348.1
9928.7
6862.8
5014.6
5780.1

income-statement-row.row.income-tax-expense

2867.42735.44068.93378.5
2200.1
2344.2
1804.1
1642.8

income-statement-row.row.net-income

6587.237810.412116.69969.6
7728.6
4518.6
3210.5
4137.3
类似股票
您可能还对以下内容感兴趣：
MARKSANS.NS
Marksans Pharma Limited.
159.55 INR
NSE
2186.HK
Luye Pharma Group Ltd..
3.04 HKD
HKSE
PTKFY
PT Kalbe Farma Tbk..
17.03 USD
PNK
VIRP.PA
Virbac SA.
334 EUR
EURONEXT
DSKYF
Daiichi Sankyo Company, Limited.
33.91 USD
PNK
ALPMF
Astellas Pharma Inc..
10.035 USD
PNK
NGLFINE.NS
NGL Fine-Chem Limited.
2128.05 INR
NSE
BMY
Bristol-Myers Squibb Company.
43.67 USD
NYSE
ORNBV.HE
Orion Oyj.
36.4 EUR
HEL
CHGCF
Chugai Pharmaceutical Co., Ltd..
32.43 USD
PNK
NVS
Novartis AG.
99.6 USD
NYSE

常见问题

什么是 Gland Pharma Limited (GLAND.NS) 总资产是多少？

Gland Pharma Limited (GLAND.NS) 总资产为 87775350000.000.

什么是企业年收入？

年收入为 29185790000.000.

企业利润率是多少？

公司利润率为 0.605.

什么是公司自由现金流？

自由现金流为 35.155.

什么是企业净利润率？

净利润率为 0.134.

企业总收入是多少？

总收入为 0.189.

什么是 Gland Pharma Limited (GLAND.NS) 净利润？{{符号}}净利润（净收入）是多少？

净利润（净收入）为 7810430000.000.

公司总债务是多少？

债务总额为 44530000.000.

营业费用是多少？

运营支出为 10611470000.000.

公司现金是多少？

企业现金为 -21447340000.000.